Delivery Order SPE2DX15D2006-BL91
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $88,724.27 firm fixed-price delivery order is for the supply of 4555504804 MENACTRA VIAL 0.5ML, a pharmaceutical product, with a completion date of November 24, 2021. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $96,781.20 Firm Fixed Price delivery order is for the supply of MENACTRA VIAL 0.5ML, a vaccine product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary mechanism for Cencora, Inc. to provide a comprehensive...
- This federal contract award, valued at $124,950.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award covers the delivery of MENACTRA VIAL 0.5ML vaccines, a critical medical commodity for government healthcare programs. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm that provides a wide range...
- This federal contract award, valued at $124,292.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Menactra vaccine vials, a critical medical product for infectious disease prevention. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MENACTRA VIAL 0.5ML, a vaccine product. The contract is a Delivery Order with a Firm Fixed Price valued at $15,247.60 and has a completion date of February 10, 2022. Amerisourcebergen is the prime contractor for this award, which is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $125,994.20 firm fixed-price delivery order is for the procurement of MENACTRA VIAL 0.5ML, a vaccine product. The contract has an ultimate completion date of July 17, 2015. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Menactra vaccines. The $84,687.31 firm-fixed-price delivery order was awarded on June 1, 2022, with a completion date of June 2, 2022. The contract was not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $124,893.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Menactra vaccine vials (0.5 mL) to support military healthcare programs. The contract has an ultimate completion date of June 26, 2015. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $89,315.00 firm fixed-price delivery order is for the supply of MENACTRA vaccine vials under contract SPE2DB20D3103. The contract is designated as a non-set-aside, full and open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $83,699.48, is for the delivery of MENACTRA VIAL 0.5ML medical products. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
- SPE2DX15D2006Indefinite Delivery Contract
- SPE2DX15D2006-BL91Delivery Order
This federal contract award, valued at $237,750.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MENACTRA VIAL 0.5ML, a vaccine product, with a completion date of November 19, 2015. This contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $237.8k | 11/16/15 |